{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:48:07Z","timestamp":1790812087935,"version":"4.1.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Rosacea is a chronic inflammatory disorder that primarily affects the facial region, significantly impacting quality of life (QOL). Outcomes in patients with rosacea may vary significantly depending on ethnicity, climatic conditions, healthcare system and cultural background. After unifying these factors, outcomes in rosacea should be evaluated over the long term.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To examine long-term outcomes in Japanese patients with rosacea using data obtained from a single institution.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective observational study, data from 63 Japanese patients with rosacea, including 42 patients who were followed up over 1 year, were analysed. Patients were treated with topical agents, with or without oral minocycline, and advised to avoid common triggers such as sun exposure and skin dryness. These data were evaluated using the Dermatology Life Quality Index (DLQI), visual analogue scale (VAS) and Investigator\u2019s Global Assessment (IGA) scoring systems.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Baseline data for the 63 patients showed that QOL was commonly impaired by uncomfortable sensations, such as itch, as well as by disfigurement. Most patients considered rosacea to have a small-to-moderate impact on their lives. DLQI scores were significantly correlated with VAS scores for itch, burning sensation, flushing and hypersensitivity. IGA scores were significantly correlated with VAS scores for flushing and with DLQI scores. Follow-up data for 42 patients over 1 year showed that VAS scores for itch, burning sensation, flushing and hypersensitivity, as well as DLQI and IGA scores, were significantly decreased over time. Topical therapies did not affect the scores throughout the clinical course.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study was conducted at a single institution in a specific geographical and climatic setting for Japanese patients with rosacea. These findings may inform follow-up care for Japanese patients and contribute to the exploration of ethnic and geographical variations in the presentation and progression of rosacea.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/skinhd\/vzaf124","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T12:53:46Z","timestamp":1766667226000},"page":"138-145","source":"Crossref","is-referenced-by-count":2,"title":["One-year outcome trends in Japanese patients with rosacea: insights from a real-world study"],"prefix":"10.1093","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0125-8930","authenticated-orcid":false,"given":"Yoshimasa","family":"Nobeyama","sequence":"first","affiliation":[{"name":"Department of Dermatology, The Jikei University School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Aihara","sequence":"additional","affiliation":[{"name":"Ai Dermatology Clinic , Utsunomiya ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"2026033107432396400_vzaf124-B1","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/1346-8138.17411","article-title":"Rosacea in East Asian populations: clinical manifestations and pathophysiological perspectives for accurate diagnosis","volume":"51","author":"Nobeyama","year":"2024","journal-title":"J Dermatol"},{"key":"2026033107432396400_vzaf124-B2","doi-asserted-by":"crossref","first-page":"adv40053","DOI":"10.2340\/actadv.v104.40053","article-title":"Health-related quality of life of patients with rosacea: a systematic review and meta-analysis of real-world data","volume":"104","author":"Chiu","year":"2024","journal-title":"Acta Derm Venereol"},{"key":"2026033107432396400_vzaf124-B3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1477-7525-4-46","article-title":"Japanese version of the Dermatology Life Quality Index: validity and reliability in patients with acne","volume":"4","author":"Takahashi","year":"2006","journal-title":"Health Qual Life Outcomes"},{"key":"2026033107432396400_vzaf124-B4","first-page":"299","article-title":"Treatment of papulopustular rosacea with sodium sulfacetamide 10%\/sulfur 5% emollient foam","volume":"8","author":"Trumbore","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"2026033107432396400_vzaf124-B5","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/bjd.15155","article-title":"DOMINO, doxycycline 40mg vs. minocycline 100mg in the treatment of rosacea: a randomized, single-blinded, noninferiority trial, comparing efficacy and safety","volume":"176","author":"van der Linden","year":"2017","journal-title":"Br J Dermatol"},{"key":"2026033107432396400_vzaf124-B6","first-page":"30","article-title":"The effect of pulsed dye laser on the dermatology life quality index in erythematotelangiectatic rosacea patients: an assessment","volume":"6","author":"Shim","year":"2013","journal-title":"J Clin Aesthet Dermatol"},{"key":"2026033107432396400_vzaf124-B7","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jaad.2004.04.010","article-title":"Pulsed dye laser treatment of rosacea improves erythema, symptomatology, and quality of life","volume":"51","author":"Tan","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"2026033107432396400_vzaf124-B8","first-page":"1","article-title":"Comparative effectiveness of purpuragenic 595nm pulsed dye laser versus sequential emission of 595nm pulsed dye laser and 1,064nm Nd:YAG laser: a double-blind randomized controlled study","volume":"28","author":"Campos","year":"2019","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"2026033107432396400_vzaf124-B9","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00403-021-02259-2","article-title":"Efficacy and safety of \u00adnon-insulated fractional microneedle radiofrequency for treating difficult-to-treat rosacea: a 48-week, prospective, observational study","volume":"314","author":"Wang","year":"2022","journal-title":"Arch Dermatol Res"},{"key":"2026033107432396400_vzaf124-B10","first-page":"2285","article-title":"Botulinum toxin A alleviates persistent erythema and flushing in patients with erythema telangiectasia rosacea","volume":"12","author":"Yang","year":"2022","journal-title":"Dermatol Ther (Heidelb)"},{"key":"2026033107432396400_vzaf124-B11","first-page":"577","article-title":"Decorative cosmetics improve the quality of life in patients with disfiguring skin diseases","volume":"12","author":"Boehncke","year":"2002","journal-title":"Eur J Dermatol"},{"key":"2026033107432396400_vzaf124-B12","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1093\/hmg\/ddy184","article-title":"Assessment of rosacea symptom severity by genome-wide association study and expression analysis highlights immuno-inflammatory and skin pigmentation genes","volume":"27","author":"Aponte","year":"2018","journal-title":"Hum Mol Genet"},{"key":"2026033107432396400_vzaf124-B13","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1038\/jid.2015.53","article-title":"Assessment of the genetic basis of rosacea by genome-wide association study","volume":"135","author":"Chang","year":"2015","journal-title":"J Invest Dermatol"},{"key":"2026033107432396400_vzaf124-B14","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1468-3083.2009.03472.x","article-title":"Risk factors associated with rosacea","volume":"24","author":"Abram","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026033107432396400_vzaf124-B15","first-page":"597","article-title":"Rosacea: 244 Tunisian cases","volume":"88","author":"Khaled","year":"2010","journal-title":"Tunis Med"},{"key":"2026033107432396400_vzaf124-B16","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1631\/jzus.B1100179","article-title":"Facial dermatosis associated with Demodex: a case-control study","volume":"12","author":"Zhao","year":"2011","journal-title":"J Zhejiang Univ Sci B"},{"key":"2026033107432396400_vzaf124-B17","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/1346-8138.16596","article-title":"Perspectives on rosacea patient characteristics and quality of life using baseline data from a phase 3 clinical study conducted in Japan","volume":"49","author":"Yamasaki","year":"2022","journal-title":"J Dermatol"},{"key":"2026033107432396400_vzaf124-B18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/bjd.15122","article-title":"Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel","volume":"176","author":"Tan","year":"2017","journal-title":"Br J Dermatol"},{"key":"2026033107432396400_vzaf124-B19","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1067\/mjd.2002.120625","article-title":"Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea","volume":"46","author":"Wilkin","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"2026033107432396400_vzaf124-B20","first-page":"448","article-title":"Real-world evidence for the treatment of rosacea with sulfur or metronidazole preparation in Japanese patients","volume":"6","author":"Nobeyama","year":"2023","journal-title":"JMA J"},{"key":"2026033107432396400_vzaf124-B21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI) \u2013 a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"2026033107432396400_vzaf124-B22","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/09546634.2017.1343435","article-title":"Defining treatment success in rosacea as \u2018clear\u2019 may provide multiple patient benefits: results of a pooled analysis","volume":"28","author":"Webster","year":"2017","journal-title":"J Dermatolog Treat"},{"key":"2026033107432396400_vzaf124-B23","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1111\/jocd.14546","article-title":"Impacts of skin disorders associated with facial discoloration on quality of life: novel insights explaining discordance between life quality scores and willingness to pay","volume":"21","author":"Yang","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"2026033107432396400_vzaf124-B24","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1365-2133.2010.09894.x","article-title":"The impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalities","volume":"163","author":"Aksoy","year":"2010","journal-title":"Br J Dermatol"},{"key":"2026033107432396400_vzaf124-B25","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.2147\/CCID.S390921","article-title":"A cross-sectional study on the relationship between rosacea severity and quality of life or psychological state","volume":"15","author":"Yang","year":"2022","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2026033107432396400_vzaf124-B26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jdermsci.2022.11.004","article-title":"The temperature-sensitive receptors TRPV4 and TRPM8 have important roles in the pruritus of rosacea","volume":"108","author":"Zhou","year":"2022","journal-title":"J Dermatol Sci"},{"key":"2026033107432396400_vzaf124-B27","first-page":"1008","article-title":"Impact of environmental factors on the severity of rosacea: multicentre observational study","volume":"14","author":"Tilwani","year":"2024","journal-title":"Eur J Cardiovasc Med"},{"key":"2026033107432396400_vzaf124-B28","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.jaad.2018.08.049","article-title":"Global epidemiology and clinical spectrum of rosacea, highlighting skin of color: review and clinical practice experience","volume":"80","author":"Alexis","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2026033107432396400_vzaf124-B29","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/1346-8138.16317","article-title":"Characterization of rosacea patients in Tohoku area of Japan: retrospective study of 340 rosacea cases","volume":"49","author":"Wada-Irimada","year":"2022","journal-title":"J Dermatol"},{"key":"2026033107432396400_vzaf124-B30","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1159\/000525024","article-title":"Characteristics of rosacea and similar diseases in patients wearing face masks","volume":"8","author":"Nobeyama","year":"2022","journal-title":"Skin Appendage Disord"}],"container-title":["Skin Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/6\/2\/138\/66794399\/vzaf124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/6\/2\/138\/66794399\/vzaf124.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T11:43:29Z","timestamp":1774957409000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/skinhd\/article\/6\/2\/138\/8466212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,6]]},"published-print":{"date-parts":[[2026,3,31]]}},"URL":"https:\/\/doi.org\/10.1093\/skinhd\/vzaf124","relation":{},"ISSN":["2690-442X"],"issn-type":[{"value":"2690-442X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2026,2,6]]}}}